ECM
NVS icon

ExodusPoint Capital Management’s Novartis NVS Stock Holding History

ExodusPoint Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,501
Closed -$705K – 1910
2025
Q3 		$705K Buy
+5,501
New +$671K 0.01% 1078
2024
Q3 		– Sell
-120,170
Closed -$12.8M – 1953
2024
Q2 		$12.8M Buy
+120,170
New +$12.1M 0.09% 211
2023
Q3 		– Sell
-73,754
Closed -$7.44M – 2005
2023
Q2 		$7.44M Sell
73,754
-96,940
-57% -$9.7M 0.06% 317
2023
Q1 		$15.7M Buy
+170,694
New +$14.9M 0.13% 168
2022
Q4 		– Sell
-108,751
Closed -$8.27M – 1974
2022
Q3 		$8.27M Buy
108,751
+102,783
+1,722% +$8.52M 0.11% 258
2022
Q2 		$504K Buy
+5,968
New +$524K 0.01% 1344
2022
Q1 		– Sell
-6,880
Closed -$602K – 2538
2021
Q4 		$602K Buy
+6,880
New +$571K 0.01% 1305
2020
Q4 		– Sell
-16,297
Closed -$1.42M – 2259
2020
Q3 		$1.42M Buy
+16,297
New +$1.41M 0.03% 529
2020
Q2 		– Sell
-2,546
Closed -$210K – 1945
2020
Q1 		$210K Sell
2,546
-13,951
-85% -$1.24M 0.01% 771
2019
Q4 		$1.56M Buy
16,497
+6,794
+70% +$610K 0.03% 407
2019
Q3 		$843K Buy
+9,703
New +$871K 0.03% 442
2019
Q1 		– Sell
-3,156
Closed -$243K – 735
2018
Q4 		$243K Buy
+3,156
New +$246K 0.02% 230

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ExodusPoint Capital Management's NVS Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of Novartis (NVS) in Q4 2025, closing a stake of 5,501 shares — an estimated $705K sold.

ExodusPoint Capital Management first reported a position in NVS in Q4 2018 and held it in 12 quarters. The position peaked at $15.7M in Q1 2023. 1,515 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 5,501 Novartis shares in Q4 2025, an estimated $705K.
  • ExodusPoint Capital Management first reported a position in Novartis in Q4 2018 and held it in 12 quarters.
  • ExodusPoint Capital Management's Novartis position peaked at $15.7M in Q1 2023.
  • 1,515 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.